1. No category

PROGRAM
R&D Network - Antibody-drug conjugates
Time: February 4th 2015, kl 14.00 – 17.00
Venue: Auditorium, Stråleterapibygget, inngang J, OUS Radium Hospital,
Ullernchausseen 70.
PROGRAM
Moderator: Arne Kolstad, MD, Dept. of Oncology, OUS Radiumhospitalet
14:00–14:15
Registration and coffee
14:15–14:30
Introduction to the topic antibody-drug conjugates
- Arne Kolstad, MD, Dept. of Oncology, OUS Radiumhospitalet
14:30–15:00
“Development of Antibody Drug Conjugates in hematologic malignancies”
- Dr Rodney B. Smith MD, Senior International Medical Director, Roche
15:00–15:40
International key note speaker:
"Antibody-drug conjugates and new treatment options"
- Petter Veiby, PhD, global head of BioTherapeutics, Oncology DDU at Takeda
Pharmaceuticals International, US.
Q&A session
10 min coffee break
16:00–16:30
Clinical perspectives:
“Antibody-drug conjugates in treatment of lymphoma cancer patients”
- Alexander Fosså, MD, Dept. of Oncology, OUS Radiumhospitalet
16:30–17:00
Biotech perspective:
“In pipeline - Phase I studies”
- Jostein Dahle, CSO, Nordic Nanovector
17:00 – 19:00 Networking session with light refreshments
We look forward to an interesting evening!
SIGN UP HERE
Any questions, please contact [email protected]